Follicular lymphoma grade II, unspecified site
ICD-10 C82.10 is a billable code used to indicate a diagnosis of follicular lymphoma grade ii, unspecified site.
Follicular lymphoma grade II is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. It is classified as a low to intermediate-grade lymphoma, indicating a moderate growth rate. This condition typically presents with painless lymphadenopathy, and it can involve multiple lymph node regions or extranodal sites. The unspecified site designation indicates that the exact location of the lymphoma has not been determined or documented. Patients may experience B-symptoms, which include fever, night sweats, and weight loss, indicating a more aggressive disease course. Diagnosis is often confirmed through lymph node biopsy and immunophenotyping. Treatment options may include watchful waiting, chemotherapy, immunotherapy, or radiation therapy, depending on the stage of the disease and the patient's overall health. The prognosis varies, with many patients achieving long-term remission, although the disease can be relapsing in nature.
Detailed documentation of diagnosis, staging, treatment plans, and follow-up care.
Patients presenting with lymphadenopathy, B-symptoms, or those undergoing treatment for follicular lymphoma.
Ensure accurate grading and staging are documented to support coding and treatment decisions.
Comprehensive reports on biopsy results, including histological grading and immunophenotyping.
Biopsy specimens from lymph nodes or extranodal sites for diagnosis confirmation.
Pathology reports must clearly indicate the grade and type of lymphoma for accurate coding.
Used when a biopsy is performed to confirm the diagnosis of follicular lymphoma.
Pathology report must include the diagnosis and grade.
Pathologists should ensure accurate grading and type identification.
The grade indicates the aggressiveness of the lymphoma, with higher grades typically associated with a more rapid progression and different treatment approaches.
